← Open Payments lookup

PAUL KLAVERWEIDEN: Open Payments

NPI 1760984454 · FRUITLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,538 in 82 payments from 17 companies in 2025. Trend: 2023 $5,321 · 2024 $900 · 2025 $1,538

Food & beverage: $1,538
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.11$179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$169
ABBVIE INC.11$154
Vanda Pharmaceuticals Inc.7$146
Axsome Therapeutics, Inc.6$124
Alkermes, Inc.6$121
Supernus Pharmaceuticals, Inc.5$102
E.R. Squibb & Sons, L.L.C.4$95
Neurocrine BioSciences, Inc.4$87
IDORSIA PHARMACEUTICALS US INC4$81

Products named: CAPLYTA, VRAYLAR, Auvelity, ARISTADA, Qelbree, REXULTI, COBENFY, UZEDY.

Industry payments across MD — which companies pay providers there.